🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase I study is designed to determine the excretion balance of radioc...
Status
Completed
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02835976
Treatments Being Tested
This is a 24-week phase 1b, randomized, double-blind, placebo-controlled, p...
Status
Completed
Location
Timone University Hospital, Neurology Department, UMR CRMBM CNRS 6612
Start Date
2013-04
Trial ID
NCT01808885
Treatments Being Tested
The purpose of this study is to test the effect of TRO19622 on peripheral n...
Status
Completed
Location
Centre Hospitalier de Versailles Hôpital André Mignot Service d'Hématologie-Oncologie
Start Date
2009-03
Trial ID
NCT00876538
Treatments Being Tested
The purpose of this study is to assess the safety, the tolerability and the...
Status
Completed
Location
CHU AMIENS, Service d'Hépato-Gastroentérologie
Start Date
2008-04-15
Trial ID
NCT00666016
The purpose of this study is to assess the efficacy and safety of TRO19622 ...
Status
Completed
Location
Univerity Hospital OSIJEK, Department for Diabetes and Endocrinology, J.Huttlera 4
Start Date
2007-05
Trial ID
NCT00496457
Treatments Being Tested
The purpose of this open-label, single arm study is to further evaluate lon...
Status
Completed
Location
UZ Gent
Start Date
2016-01-20
Trial ID
NCT02628743
Treatments Being Tested
Assess the efficacy and the safety of olesoxime in SMA type 2 or type 3 non...
Status
Completed
Location
University Hospitals
Start Date
2010-11
Trial ID
NCT01302600
The purpose of the assay is to assess the safety and the efficacy of TRO196...
Status
Completed
Location
University Hospital Gasthuisberg - Dept Neurology - Herestraat 49
Start Date
2009-04-30
Trial ID
NCT00868166
Treatments Being Tested
The purpose of the assay is to assess the safety of TRO19622 330 mg QD as a...
Status
Completed
Location
University Hospital Gasthuisberg - Dept Neurology - Herestraat 49
Start Date
2010-10
Trial ID
NCT01285583
Treatments Being Tested